Filing Details

Accession Number:
0001209191-17-054277
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-28 17:15:55
Reporting Period:
2017-09-23
Accepted Time:
2017-09-28 17:15:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411906 Ampio Pharmaceuticals Inc. AMPE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1109775 H Philip Coelho C/O Ampio Pharmaceuticals, Inc.
373 Inverness Parkway, Suite 200
Englewood CO 80112
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-27 10,000 $0.63 104,727 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2017-09-23 30,000 $0.00 30,000 $0.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,000 2027-09-23 No 4 A Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $0.6196 to $0.6322. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. The stock option vests and becomes exercisable in 12 equal monthly installments from the date of grant.